It has been a year and a half since the Medicines Verification System became operational in Latvia. In order to learn about the current events, look back at what has been achieved and look at the future challenges, we had a conversation with Inese Erdmane, Executive Director of the Latvian Medicines Verification Organisation (LZVO).
The transition period in the relationship between the European Union (EU) and the United Kingdom is due to end on 31 December 2020. Henceforth, EU legal acts prohibiting or restricting import and export of active substances, medical devices, products of human origin will be applicable to the United Kingdom as to any other third country.
To date, 1,238 users have connected to the medicines verification system in Latvia – pharmacies, hospitals, health centres, doctor's practices and other medical institutions, as well as wholesalers and dental institutions and practices. In May, three new users joined the system. The connection to the system continues steadily with low intensity.